Skip to main content
logo
Cynata Therapeutics Limited (ASX:CYP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0120
0.00 (0.00%)
Oct 30, 2026, 9:59 AM AEDT

Cynata Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
1.711.711.892.321.657.77
Revenue Growth
0%-9.21%-18.59%39.98%-78.71%402.60%
Gross Profit
1.711.711.892.321.657.77
Operating Income
-7.97-7.97-9.61-10.23-14.89-6.07
Net Income
-9.25-9.25-9.39-9.74-14.28-5.45
Earnings Per Share
-0.04-0.04-0.05-0.05-0.10-0.04
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
0.90.95.056.2116.1723.8
Net Cash Growth
-65.33%-82.23%-18.62%-61.62%-32.06%-10.92%
Net Cash Per Share
0.000.000.020.030.110.17
Cash & Investments
0.90.95.056.2116.1723.8

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-6.74-6.74-8.72-9.96-14.28-3.3
Free Cash Flow
-6.74-6.74-8.72-9.96-14.28-3.3
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-465.83%-465.83%-509.82%-441.78%-899.97%-78.09%
Pretax Margin
-540.36%-540.36%-498.14%-420.82%-863.05%-70.08%
Profit Margin
-540.36%-540.36%-498.14%-420.82%-863.05%-70.08%

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-103.85103.85103.85103.85103.85
PS Ratio
1.711.9917.9822.8813.576.64